Our previous studies have demonstrated that ubiquitin C-terminal hydrolase L1 (UCHL1), which is a member of the DUB family, could promote resistance to pemetrexed in non-small cell lung cancer (NSCLC) by up-regulating thymidylate synthase (13). Here, UCHL1 is linked to non-small cell lung carcinoma.